JENNIFER BRITT: Open Payments
NPI 1568404648 · IRMO, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,550 in 159 payments from 24 companies in 2025. Trend: 2023 $1,502 · 2024 $2,330 · 2025 $2,550
Food & beverage: $2,550
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 17 | $323 |
| AstraZeneca Pharmaceuticals LP | 17 | $317 |
| ABBVIE INC. | 25 | $268 |
| Novo Nordisk Inc | 14 | $258 |
| Amgen Inc. | 17 | $172 |
| Corcept Therapeutics | 10 | $165 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $152 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $138 |
| Abbott Laboratories | 8 | $120 |
| Dexcom, Inc. | 3 | $113 |
Products named: REXULTI, Korlym, Kerendia, XIFAXAN, Wegovy, BREZTRI, OTEZLA, VRAYLAR.
Industry payments across SC — which companies pay providers there.
